Dallas Ebola Patient Receives Experimental Drug

October 6, 2014 6:55 PM

29 0

Thomas Eric Duncan, the first patient to be diagnosed with Ebola in the United States, is now receiving an experimental drug called brincidofovir, according to a statement from Texas Health Presbyterian Hospital Dallas. Duncan is currently in critical condition.

Brincidofovir, which is still in the experimental phase, was just approved by the FDA on Monday for use in patients with Ebola, according to a statement by biopharmaceutical company Chimerix. Test tube experiments have revealed that brincidofovir acts against Ebola in the same way the drug fights ot...

Read more

To category page